{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-018220","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2026-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.853496+00:00","generated_at":"2026-05-15T05:08:53.588099+00:00","sec_items":["1.01","2.03","3.03","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Celularity closes $13.3M NexGel asset sale; Helena default notice on $1.97M note","bullets":["Closed asset sale to NexGel for $13.3M ($8.3M cash + $5M note), retired ~$13M debt.","Eligible for up to $20M milestones and royalties on net sales.","Helena exchanged for $1.97M note at 18%; default notice for late 10-K; potential 115% acceleration.","Co. terminated John Haines (SVP/CAO) and Stephen Brigido resigned (President, Degenerative)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-018220","json":"https://secwatch.observer/filing/0001493152-26-018220.json","markdown":"https://secwatch.observer/filing/0001493152-26-018220.md","text":"https://secwatch.observer/filing/0001493152-26-018220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226018220/0001493152-26-018220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226018220/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:08:53.588099+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"65b160aae428962cab73e551b23c4685467e9aa1","claim":"Celularity Inc reported a default on convertible notes with Helena Global Investment Opportunities 1 Ltd. at 15% per annum.","evidence_excerpt":"On April 17, 2026, Helena delivered to the Company a notice of event of default (the “Default Notice”) under the Helena Note.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226018220/0001493152-26-018220-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Counterparty","value":"Helena Global Investment Opportunities 1 Ltd."},{"label":"Rate","value":"15% per annum"},{"label":"Event","value":"default"}],"fact_type":"debt_financing"},{"claim_id":"ef8cc7fea785ddb59509f31005bd2b307cac81db","claim":"Celularity Inc incurred convertible notes of $1,970,502.58 with Helena Global Investment Opportunities 1 Ltd. at 18.0% per annum maturing October 16, 2026.","evidence_excerpt":"for a Convertible Promissory Note in the original principal amount of $1,970,502.58 (the “Helena Note”). The Helena Note bears interest at a rate of 18.0% per annum and matures on October 16, 2026","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226018220/0001493152-26-018220-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$1,970,502.58"},{"label":"Counterparty","value":"Helena Global Investment Opportunities 1 Ltd."},{"label":"Rate","value":"18.0% per annum"},{"label":"Maturity","value":"October 16, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"740457ae9938c3c2608177d06fab845eaf869696","claim":"Celularity Inc amended Amendment No. 1 with NexGel, Inc. valued at $13.3 million (effective 2026-04-17).","evidence_excerpt":"On April 17, 2026, Celularity Inc. (the “Company”) entered into Amendment No. 1 (the “Amendment”) to that certain Asset Purchase and Exclusive License Agreement, dated as of March 6, 2026 (the “Original Agreement” and, as amended, the “Agreement”), with NexGel, Inc. (“NexGel”). Among other things, the Amendment provides that: (i) the aggregate consideration payable to the Company under the Agreement is $13.3 million, consisting of an upfront cash payment of $8.3 million on the transaction commencement date and a convertible promissory note in the original principal amount of $5.0 million with an 18-month term","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226018220/0001493152-26-018220-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"NexGel, Inc."},{"label":"Value","value":"$13.3 million"},{"label":"Effective","value":"2026-04-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}